Pharmaboardroom.com announces the release of its free report on the pharmaceutical and healthcare sectors in Indonesia
The poor state of Indonesia’s healthcare system has turned ‘improving quality’ into the top priority of the government of Indonesia. Better quality of care has become especially important as the fourth most populated country in the world moves into full traction with its plans to achieve universal health care coverage. This comprehensive free report examines the facts and opinions behind the political and business decisions currently shaping the market.
Indonesia’s Minister of Health, Nafsiah Mboi, Phd, interviewed as part of this free report, explains how the government is trying to improve care across the country. “So far, we have been preparing rigorously to improve the quality of care. For healthcare facilities, our vision is a very strong primary care network combined with a good quality referral system.” According to the Ministry, Indonesia now has roughly 9,500 primary care centers or one for every 30,000 people. “Although these numbers match the required standards, we need to work on improving the quality at primary care level,” she explains. “In terms of hospital care we now have 2,138 hospitals, 829 which are government owned, across the country. These hospitals have standards and accreditation which guarantee the quality of care that we need.”
According to the Ministry of Health, 72 percent of the population, just over 176 million Indonesians, were already part of some type of health financing scheme. Now Indonesia’s policymakers are committed to covering every citizen by 2019. The implementation of universal healthcare coverage will start in January 2014 and is widely seen as a significant step forward for Indonesia’s 238 million people. With only 2,7% of GDP spent on healthcare currently, this figure seems set to expand in the years to come.
Badan Penyelenggara Jaminan Sosial, or BPJS as the system is locally referred to, aims to drastically increase the quality and access to medicines and medical treatment to the entire Indonesian population. In 2014, an amount of IDR 1.75 trillion (USD 1.7 billion) will be provided to cover the poor and the ‘near poor’, according to Indonesia’s Vice Minister of Health, Mukti Ali Ghufrom.
Most multinational companies (MNCs) do not expect to play a major role within BPJS but, despite the vast volume, serving BPJS will not be easy or cheap for local manufacturers either. Not only are they required to ramp up manufacturing capacity to serve a growing market, permits to manufacture – due to Indonesia’s Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (jointly referred to as PIC/S) adherence – have become stricter than ever.
Written after exclusive interviews with the country’s leading decision makers, from local and multinational companies, manufacturers, distributors, experts, legislators, this is a unique resource for those looking beyond figures.
Featuring:
- Universal coverage: weaving Indonesia together
- Interview: Dr. Nafsiah Mboi, Ped, MPH Minister of Health of the Republic of Indonesia
- Interview: Johannes Setijono, Chairman, Kalbe Farma
- Family grip on local pharma
- PIC/S & pennies
Michael Comi
Pharmaboardroom.com
email us here
+44 203 356 4889
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
